This year CUPIDO arouse interest during the European Society of Cardiology Congress, one of the world’s largest and most influential cardiovascular event contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2019 took place 31 August to 4 September at the Paris Expo Porte de Versailles, Paris – France.
The interest is well deserved as this proof of concept has never been shown before for miRNAs and inhalation. This important work is at the core of the CUPIDO project which is now in the process of scaling up the production for the evaluation in large-animal models, thus paving the way for future health applications of the CUPIDO inhalable nanoparticles. The efforts of the whole Consortium are well paid back by this recognition at such important scientific event.
